INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2011
|
Total net assets |
£101.3m |
|
NAV per share |
180.8p |
|
Share price |
153.5p |
|
Total value of unquoted investments |
£25.4m |
|
Total number of portfolio companies |
63 |
|
Cash |
1% NAV |
|
Cash committed and reserved to unquoted investments |
10% NAV |
|
Portfolio companies with < 1 year of cash |
12% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
5.81 |
|
Cadent |
5.60 |
|
Teva |
5.57 |
|
Insulet |
4.91 |
|
Gilead Sciences |
4.56 |
|
Celgene |
4.19 |
|
Shire |
4.19 |
|
Micromet |
3.80 |
|
Pharmasset |
3.70 |
|
Aptiv |
2.77 |
|
|
----------- |
|
Total |
45.10 |
|
Geographical Allocation |
% |
|
United States |
72 |
|
Europe |
20 |
|
Israel |
6 |
|
Australia |
1 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
74 |
|
Unquoted |
25 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 JULY 2011